Association between lower- ing LDL-C and cardiovascular risk reduction among different thera- peutic interventions: a systematic review and meta-analysis. JAMA. 2016;316:1289 97. 2.1.3. LDL-C and Other Risk Factors S2.1.3-1. Wilson PW, D Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97: 1837-47. S2.1.3-2. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce ath- erosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1 45. S2.1.3-3. Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA. 2014;311:1406 15. S2.1.3-4. Mora S, Wenger NK, Cook NR, et al. Evaluation of the pooled cohort risk equations for cardiovascular risk prediction in a multi- ethnic cohort from the Women s Health Initiative. JAMA Intern Med. 2018;178:1231 40. 2.2. Measurements of LDL-C and Non-HDL-C S2.2-1. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118:2047 56. S2.2-2. Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem. 2011;57:482 9. S2.2-3. Mora S, Rifai N, Buring JE, et al. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27331 women. Clin Chem. 2009;55:888 94. S2.2-4. Sidhu D, Naugler C. Fasting time and lipid levels in a commu- nity-based population: a cross-sectional study. Arch Intern Med. 2012;172:1707 10. CLINICAL STATEMENTS AND GUIDELINES S2.2-5. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipopro- teins, and risk of vascular disease. JAMA. 2009;302:1993 2000. S2.2-6. 